Table of Contents
ISRN Infectious Diseases
Volume 2013 (2013), Article ID 269728, 7 pages
http://dx.doi.org/10.5402/2013/269728
Research Article

Oral Lesions: Poor Markers of Virologic Failure in HIV-Infected Patients on Antiretroviral Therapy

1Department of Epidemiology, School of Public Health, University of Alabama at Birmingham, Birmingham, AL 35294, USA
2Department of Behavioral Science, The University of Texas MD Anderson Cancer Center, 1155 Pressler St., Unit 1330, CPB3.3202, Houston, TX 77030-4009, USA
3Department of Infectious Diseases, School of Medicine, University of Alabama at Birmingham, Birmingham, AL 35294, USA
4Vanderbilt Institute for Global Health, Vanderbilt University, Nashville, TN 37203, USA
5Department of Biostatistics, School of Public Health, University of Alabama at Birmingham, Birmingham, AL 35294, USA
6Department of Predoctoral General Dentistry, School of Dentistry, University of Alabama at Birmingham, Birmingham, AL 35294, USA
7Sparkman Center for Global Health, University of Alabama at Birmingham, Birmingham, AL 35294, USA

Received 18 September 2012; Accepted 14 October 2012

Academic Editors: G. A. Funk and G. Simo

Copyright © 2013 Irene Tami-Maury et al. This is an open access article distributed under the Creative Commons Attribution License, which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited.

Linked References

  1. W. Birnbaum, T. A. Hodgson, P. A. Reichart, W. Sherson, S. W. Nittayannanta, and T. E. Axell, “Prognostic significance of HIV-associated oral lesions and their relation to therapy,” Oral Diseases, vol. 8, no. 2, pp. 110–114, 2002. View at Publisher · View at Google Scholar · View at Scopus
  2. J. S. Greenspan, “Sentinels and signposts: the epidemiology and significance of the oral manifestations of HIV disease,” Oral Diseases, vol. 3, no. 1, pp. S13–S17, 1997. View at Google Scholar · View at Scopus
  3. V. Margiotta, G. Campisi, S. Mancuso, V. Accurso, V. Abbadessa, and P. Giaccone, “HIV infection: oral lesions, CD4+ cell count and viral load in an italian study population,” Journal of Oral Pathology and Medicine, vol. 28, no. 4, pp. 173–177, 1999. View at Google Scholar · View at Scopus
  4. M. M. Coogan, J. Greenspan, and S. J. Challacombe, “Oral lesions in infection with human immunodeficiency virus,” Bulletin of the World Health Organization, vol. 83, no. 9, pp. 700–706, 2005. View at Google Scholar · View at Scopus
  5. T. A. Hodgson, D. Greenspan, and J. S. Greenspan, “Oral lesions of HIV disease and HAART in industrialized countries,” Advances in Dental Research, vol. 19, no. 1, pp. 57–62, 2006. View at Google Scholar · View at Scopus
  6. Guideline for the use of antiretroviral agents in HIV-1 infected aults and adolescents. Developed by the DHHS Panel on Antiretroviral Guidelines for Adults and Adolescents—A working Group of the Office of AIDS Research Advisory Council, 2006.
  7. J. A. C. Sterne, M. A. Hernán, B. Ledergerber et al., “Long-term effectiveness of potent antiretroviral therapy in preventing AIDS and death: a prospective cohort study,” The Lancet, vol. 366, no. 9483, pp. 378–384, 2005. View at Publisher · View at Google Scholar · View at Scopus
  8. A. R. Tappuni and G. J. P. Fleming, “The effect of antiretroviral therapy on the prevalence of oral manifestations in HIV-infected patients: a UK study,” Oral Surgery, Oral Medicine, Oral Pathology, Oral Radiology, and Endodontics, vol. 92, no. 6, pp. 623–628, 2001. View at Publisher · View at Google Scholar · View at Scopus
  9. L. A. Gaitán-Cepeda, M. Martínez-González, and A. Ceballos-Salobreña, “Oral candidosis as a clinical marker of immune failure in patients with HIV/AIDS on HAART,” AIDS Patient Care and STDs, vol. 19, no. 2, pp. 70–77, 2005. View at Publisher · View at Google Scholar · View at Scopus
  10. L. L. Patton, R. McKaig, R. Strauss, D. Rogers, and J. J. Eron, “Changing prevalence of oral manifestations of human immuno-deficiency virus in the era of protease inhibitor therapy,” Oral Surgery, Oral Medicine, Oral Pathology, Oral Radiology, and Endodontics, vol. 89, no. 3, pp. 299–304, 2000. View at Publisher · View at Google Scholar · View at Scopus
  11. WHO, Antiretroviral Therapy for HIV Infection in Adults and Adolescents: Recommendations for a Public Health Approach, Edited by WHO, World Health Organization Guidelines, 2006.
  12. Candidiasis, In: Dental Issues: Oral Cancer Foundation, 2010, http://www.oralcancerfoundation.org/dental/candida.htm.
  13. M. Ravera, A. Reggiori, A. M. Agliata, and R. P. Rocco, “Evaluating diagnosis and treatment of oral and esophageal candidiasis in Ugandan AIDS patients,” Emerging Infectious Diseases, vol. 5, no. 2, pp. 274–277, 1999. View at Google Scholar · View at Scopus
  14. Candidiasis, “Oral and Esophageal,” in Guide for HIV/AIDS Clinical Care: HIV/AIDS Bureau, U.S. Department of Health and Human Services, Health Resources, and Services Administration, 2011. View at Google Scholar
  15. P. G. Pappas, C. A. Kauffman, D. Andes et al., “Clinical practice guidelines for the management of candidiasis: 2009 Update by the Infectious Diseases Society of America,” Clinical Infectious Diseases, vol. 48, no. 5, pp. 503–535, 2009. View at Publisher · View at Google Scholar · View at Scopus
  16. S. G. Revankar, S. E. Sanche, O. P. Dib, M. Caceres, and T. F. Patterson, “Effect of highly active antiretroviral therapy on recurrent oropharyngeal candidiasis in HIV-infected patients,” AIDS, vol. 12, no. 18, pp. 2511–2513, 1998. View at Google Scholar · View at Scopus
  17. L. L. Patton, “Sensitivity, specificity, and positive predictive value of oral opportunistic infections in adults with HIV/AIDS as markers of immune suppression and viral burden,” Oral Surgery, Oral Medicine, Oral Pathology, Oral Radiology, and Endodontics, vol. 90, no. 2, pp. 182–188, 2000. View at Google Scholar · View at Scopus
  18. C. S. Krawczyk, E. Funkhouser, J. M. Kilby, R. A. Kaslow, A. K. Bey, and S. H. Vermund, “Factors associated with delayed initiation of HIV medical care among infected persons attending a southern HIV/AIDS clinic,” Southern Medical Journal, vol. 99, no. 5, pp. 472–481, 2006. View at Publisher · View at Google Scholar · View at Scopus
  19. M. Mascolini, Three Biggest HIV Problems in the United States: Late Testing, Late Care, Early Dropout. In: Research Initiative, Treatment Action!: AIDS Research Consortium of Houston, 2011, http://img.thebody.com/cfa/pdfs/rita_spring_summer11.pdf#page=5.
  20. M. J. Mugavero, W. E. Norton, and M. S. Saag, “Health care system and policy factors influencing engagement in HIV medical care: piecing together the fragments of a fractured health care delivery system,” Clinical Infectious Diseases, vol. 52, supplement 2, pp. S238–S246, 2011. View at Publisher · View at Google Scholar · View at Scopus
  21. I. D. Miziara and R. Weber, “Oral candidosis and oral hairy leukoplakia as predictors of HAART failure in Brazilian HIV-infected patients,” Oral Diseases, vol. 12, no. 4, pp. 402–407, 2006. View at Publisher · View at Google Scholar · View at Scopus
  22. M. W. G. Brinkhof, F. Dabis, L. Myer et al., “Early loss of HIV-infected patients on potent antiretroviral therapy programmes in lower-income countries,” Bulletin of the World Health Organization, vol. 86, no. 7, pp. 559–567, 2008. View at Publisher · View at Google Scholar · View at Scopus
  23. L. Gardner, G. Marks, J. Craw et al., “A low-effort clinic-wide intervention improves attendance for HIV primary care,” Clinical Infectious Diseases, vol. 55, no. 8, pp. 1124–1134, 2012. View at Google Scholar
  24. D. N. Burns, C. W. Dieffenbach, and S. H. Vermund, “Rethinking prevention of HIV type 1 infection,” Clinical Infectious Diseases, vol. 51, no. 6, pp. 725–731, 2010. View at Publisher · View at Google Scholar · View at Scopus
  25. E. M. Gardner, M. P. McLees, J. F. Steiner, C. Del Rio, and W. J. Burman, “The spectrum of engagement in HIV care and its relevance to test-and-treat strategies for prevention of HIV infection,” Clinical Infectious Diseases, vol. 52, no. 6, pp. 793–800, 2011. View at Publisher · View at Google Scholar · View at Scopus
  26. “Vital signs: HIV prevention through care and treatment—United States,” MMWR. Morbidity and Mortality Weekly Report, vol. 60, pp. 1618–1623, 2011.
  27. J. F. Hilton, M. Alves, K. Anastos et al., “Accuracy of diagnoses of HIV-related oral lesions by medical clinicians, findings from the Women's Interagency HIV Study,” Community Dentistry and Oral Epidemiology, vol. 29, no. 5, pp. 362–372, 2001. View at Google Scholar · View at Scopus